In an eight week study performed on rats, hyperbaric oxygen therapy effectively improved blood pressure parameters and repressed hypertension. This clinical trial used a lower pressure protocol, using only 1.25 ATA. Though this phenomenon has been observed in clinical practice, this is the first study of its kind to demonstrate the not only the link between the two, but also the possible mechanisms that may be playing the key roles <view study> Read Less

During the various stages of arthritis, the joints and surrounding tissue are in constant attack from oxidation stressors and inflammatory reactions. This causes progressive damage and leads to the many debilities that are seen in arthritis sufferers. This study used 1.25 ATA (low pressure) hyperbaric therapy and discovered that a 3 week course of this hyperbaric dosage had a protective effect <view study> Read Less

Many sufferers from mold toxicity complain of cognitive deficits including: memory problems, inability to focus (brain fog), and slow reaction times. The addition of hyperbaric oxygen therapy was shown to cause marked improvements in these patients. These improvements were seen in only 10 sessions of hyperbaric oxygen therapy. Moreover, this study revealed that these benefits were seen at only 1.3 ATA (low pressure) and while using oxygen connections closer to room air than the conventionally-used 100% oxygen delivery systems <view study> Read Less

It is well researched that diabetics can benefit from hyperbaric oxygen therapy as a primary treatment for foot wounds, ulcers, and other hard to heal injuries. However, the major complication to diabetics is in cardiovascular disease and coronary events (CE) like sudden heart attacks, strokes, etc. The main contributing factors to this elevated risk are poor glycemic control, elevated inflammatory markers and atherosclerosis. In this study, they monitored these factors in diabetics being treated with HBOT for diabetic foot wounds. With no surprise, all parameters including fasting blood sugar, haemoglobin H1C, CRP, and lipid profiles were statistically significantly improved. The researchers concluded that the application of HBOT caused better glycemic control and had beneficial effects on atherosclerosis. With this, HBOT may be the answer in reducing risk of CE’s and therefore reducing both debilities and mortalities that are commonly observed in the diabetic population <view study> Read Less

A landmark study provided by the Ohio State University in Columbus has just been published in the Journal of Cancer Biology & Therapy and the results are consistent with the latest research validating the use of HBOT in Cancer therapy. It has already been well established that solid tumours are low in oxygen (hypoxic) and it is this factor that limits conventional therapy like chemo and radiation, and allows for resistance to congenital treatments. In this study, the addition of HBOT (90 minute sessions daily for up to 21 days at a dose of 2.0 ATA)corrected the hypoxic tumour and leading to enhancement of chemotherapeutic regimen for ovarian cancer. In addition and of extreme significance is that the application of HBOT alone caused a significant reduction in tumour size. This study confirms recent literature supporting the use of HBOT with and without conventional therapy <view study> Read Less